What changed in this filing

/stocks — the workspaceLOADING

Item 2. Management’s Discussion and Analysis

2021-11-02 compared with 2021-08-03 · 112 added, 84 removed, 134 unchanged (59% of the section changed)

1 unchanged sentence

The following discussion and analysis of Leidos Holdings, Inc.'s ("Leidos") financial condition, results of operations, and quantitative and qualitative discussion about business environment and trends should be read in conjunction with Leidos' condensed consolidated financial statements and related notes.

The following discussion contains forward-looking statements, including statements regarding our intent, belief or current expectations with respect to, among other things, trends affecting our financial condition or results of operations, backlog, our industry, the impact of our merger and acquisition activity, government budgets and spending, our business contingency plans and our ability to recover certain costs through the Coronavirus Aid, Relief and Economic Security Act ("CARES Act").

The following discussion contains forward-looking statements, including statements regarding our intent, belief or current expectations with respect to, among other things, trends affecting our financial condition or results of operations, backlog, our industry, the impact of our merger and acquisition activity, government budgets and spending, our business contingency plans, uncertainties in tax due to new tax legislation or other regulatory developments and our ability to recover certain costs through the Coronavirus Aid, Relief and Economic Security Act ("CARES Act").

Such statements are not guarantees of future performance and involve risks and uncertainties, including uncertainties relating to the coronavirus pandemic ("COVID-19") and the actions taken by authorities and us to respond, and actual results may differ materially from those in the forward-looking statements as a result of various factors.

16 unchanged sentences

Additionally, we separately present the unallocable costs associated with corporate functions as Corporate.

For the three and six months ended July 2, 2021, COVID-19 did not have a material impact to revenues and operating income.

For the three and nine months ended October 1, 2021, COVID-19 did not have a material impact to revenues and operating income.

The full extent of the impact of the COVID-19 pandemic on our operational and financial performance, including our ability to execute on programs in the expected timeframe, will depend on future developments, including the duration and spread of the pandemic and the distribution of vaccines, all of which are uncertain and cannot be predicted.

While we have been able to make some recoveries, the ultimate timing and amount of recoveries remain uncertain as they will depend on a range of government actions, including each government agency and/or contracting officer's implementation of the authority granted in Section 3610 of the CARES Act, a $2 trillion coronavirus response bill providing widespread emergency relief, including the availability of funds.

As a result of Congress passing government fiscal year ("GFY") 2021 appropriations, the relief from the CARES Act has been extended until September 30, 2021.

Section 3610 of the CARES Act, a $2 trillion coronavirus response bill providing widespread emergency relief, authorized the government to reimburse qualifying contractors for the cost of certain impacts of COVID-19.

While a portion of the recoveries that we have made are a result of Section 3610 of the CARES Act, the Act expired on September 30, 2021.

Effective October 1, 2021, we mandated a policy requiring all employees, vendors, subcontractors and visitors to be vaccinated or maintain proof of a negative COVID-19 test in order to enter a Leidos facility in the U.S.

or to attend company business events outside of our facilities.

On September 9, 2021, President Biden issued a series of executive orders to combat COVID-19, which requires us, as a federal contractor, to ensure that all of our employees are fully vaccinated by December 8, 2021, unless the employee is legally entitled to a religious or medical exemption.

We are currently assessing the impact our policy will have on our workforce and operations.

LEIDOS HOLDINGS, INC.

Business Environment and Trends

Government Markets

During the three and six months ended July 2, 2021, we generated approximately 86% and 87%, respectively, of our total revenues from contracts with the U.S.

During the three and nine months ended October 1, 2021, we generated approximately 88% and 87%, respectively, of our total revenues from contracts with the U.S.

Accordingly, our business performance is affected by the overall level of U.S.

government spending, especially on national security, homeland security and intelligence, and the alignment of our service and product offerings and capabilities with current and future budget priorities of the U.S.

Congress received the GFY 2022 President’s Budget Request on May 28, 2021.

Congress is working through the appropriations process before the end of the GFY on September 30;

however, a continuing resolution is likely.

Other potential spending packages include an infrastructure package and a budget reconciliation package.

LEIDOS HOLDINGS, INC.

Congress received the GFY 2022 President’s Budget Request on May 28, 2021 and passed a Continuing Resolution ("CR") before the GFY deadline of September 30, 2021.

The CR will fully fund the federal government at current levels through December 3, 2021 and provides $28.6 billion in disaster relief and $6.3 billion to support Afghanistan evacuees.

The House and Senate also voted to extend the debt limit waiver through December 3, 2021.

International Markets

Sales to customers in international markets represented approximately 9% of total revenues for the three and six months ended July 2, 2021.

Sales to customers in international markets represented approximately 8% of total revenues for the three and nine months ended October 1, 2021.

Our international customers include foreign governments and their agencies.

3 unchanged sentences

While we evaluate the impact of higher tariffs, currently, we do not expect tariffs to have a significant impact to our business.

LEIDOS HOLDINGS, INC.

Results of Operations

The following table summarizes our condensed consolidated results of operations for the periods presented:

Three Months Ended Six Months Ended

2020 Dollar change Percent change July 2,

Three Months Ended Nine Months Ended

2021 October 2,

2020 Dollar change Percent change October 1,

2021 October 2,

2020 Dollar change Percent change

13 unchanged sentences

Segment and Corporate Results

Three Months Ended Six Months Ended

Defense Solutions July 2,

2020 Dollar change Percent change July 2,

Three Months Ended Nine Months Ended

Defense Solutions October 1,

2021 October 2,

2020 Dollar change Percent change October 1,

2021 October 2,

2020 Dollar change Percent change

3 unchanged sentences

Operating margin 7.0 % 7.4 % 7.2 % 6.6 %

The increase in revenues for the three and six months ended July 2, 2021, as compared to the three and six months ended July 3, 2020, was primarily attributable to program wins, a net increase in volumes on certain programs and total of $37 million and $50 million, respectively, of revenues from the acquisitions of Gibbs & Cox and 1901 Group, partially offset by the completion of certain contracts.

In addition, for the three and six months ended July 2, 2021, there was a $29 million and $53 million benefit, respectively, in exchange rate movements.

The increase in operating income for the three and six months ended July 2, 2021, as compared to the three and six months ended July 3, 2020, was primarily due to program wins and a net increase in volumes on certain programs, partially offset by the completion of certain contracts.

LEIDOS HOLDINGS, INC.

Three Months Ended Six Months Ended

Civil July 2,

2020 Dollar change Percent change July 2,

The increase in revenues for the three months ended October 1, 2021, as compared to the three months ended October 2, 2020, was primarily attributable to program wins and $47 million of revenues from the acquisitions of Gibbs & Cox and 1901 Group, partially offset by the completion of contracts and a net decrease in volumes on certain programs.

The increase in revenues for the nine months ended October 1, 2021, as compared to the nine months ended October 2, 2020, was primarily attributable to program wins, a net increase in volumes on certain programs and $97 million of revenues from the acquisitions of Gibbs & Cox and 1901 Group, partially offset by the completion of certain contracts.

In addition, for the nine months ended October 1, 2021, there was a $66 million benefit in exchange rate movements.

The decrease in operating income for the three months ended October 1, 2021, as compared to the three months ended October 2, 2020, was primarily attributable to a net decrease in volumes on certain programs and the completion of certain contracts, partially offset by program wins.

The increase in operating income for the nine months ended October 1, 2021, as compared to the nine months ended October 2, 2020, was primarily due to program wins, a net increase in program volumes on certain contracts and the acquisitions of Gibbs & Cox and 1901 Group, partially offset by the completion of certain contracts.

Three Months Ended Nine Months Ended

Civil October 1,

2021 October 2,

2020 Dollar change Percent change October 1,

2021 October 2,

2020 Dollar change Percent change

3 unchanged sentences

Operating margin 7.3 % 7.0 % 7.9 % 8.7 %

The increase in revenues for the three months ended July 2, 2021, as compared to the three months ended July 3, 2020, was primarily attributable to a net increase in program volumes, program wins and a reduction of the negative impacts from COVID-19 experienced during the prior year quarter.

The increase in revenues for the six months ended July 2, 2021, as compared to the six months ended July 3, 2020, was primarily attributable to a net increase of $66 million of revenues related to L3 Harris Technologies' security and detection businesses (the "SD&A Businesses") acquired in the prior year quarter, a net increase in program volumes, program wins and a reduction of the negative impacts from COVID-19 experienced during the prior year quarter.

The decrease in operating income for the three months ended July 2, 2021, as compared to the three months ended July 3, 2020, was primarily due to a net decrease in volumes due to the timing of product deliveries on certain programs.

The decrease in operating income for the six months ended July 2, 2021, as compared to the six months ended July 3, 2020, was primarily attributable to a net decrease in volumes due to the timing of product deliveries on certain programs and increased amortization reflecting one additional month in the current quarter related to intangible assets from the acquisition of the SD&A Businesses, partially offset by a $26 million benefit from an adjustment to legal reserves related to the Mission Support Alliance joint venture during the first quarter of fiscal 2021 and on-contract growth in certain programs.

Three Months Ended Six Months Ended

Health July 2,

2020 Dollar change Percent change July 2,

LEIDOS HOLDINGS, INC.

The increase in revenues for the three months ended October 1, 2021, as compared to the three months ended October 2, 2020, was primarily attributable to program wins and a reduction of the negative impacts from COVID-19 experienced during the prior year quarter, partially offset by a net decrease in program volumes.

The increase in revenues for the nine months ended October 1, 2021, as compared to the nine months ended October 2, 2020, was primarily attributable to a net increase of $62 million of revenues related to L3 Harris Technologies' security and detection businesses (the "SD&A Businesses") acquired in the prior year, a net increase in program volumes, program wins and a reduction of the negative impacts from COVID-19 experienced during the prior year.

The increase in operating income for the three months ended October 1, 2021, as compared to the three months ended October 2, 2020, was primarily due to improved performance on certain programs and lower amortization of intangible assets related to the acquisition of the SD&A Businesses, partially offset by fewer product deliveries on certain programs.

The decrease in operating income for the nine months ended October 1, 2021, as compared to the nine months ended October 2, 2020, was primarily attributable to a net decrease in volumes due to the timing of product deliveries on certain programs, partially offset by a $26 million benefit from an adjustment to legal reserves related to the Mission Support Alliance joint venture during the first quarter of fiscal 2021.

Three Months Ended Nine Months Ended

Health October 1,

2021 October 2,

2020 Dollar change Percent change October 1,

2021 October 2,

2020 Dollar change Percent change

1 unchanged sentence

Revenues $ 682 $ 520 $ 162 31.2 % $ 1,918 $ 1,449 $ 469 32.4 %

Operating income 107 1 106 NM 209 74 135 182.4 %

Operating income 130 75 55 73.3 % 339 149 190 127.5 %

Operating margin 19.1 % 14.4 % 17.7 % 10.3 %

The increase in revenues for the three and six months ended July 2, 2021, as compared to the three and six months ended July 3, 2020, was primarily attributable to a net increase in volumes on certain programs, program wins and an approximately $96 million reduction of the negative impacts of COVID-19 experienced during the prior year quarter.

The increase in operating income for the three and six months ended July 2, 2021, as compared to the three and six months ended July 3, 2020, was primarily due to a net increase in volumes on higher margin programs, an approximately $57 million reduction of the negative impacts of COVID-19 experienced during both the prior year quarter and prior year and an $11 million asset impairment charge in the prior year quarter.

Three Months Ended Six Months Ended

Corporate July 2,

2020 Dollar change Percent change July 2,

The increase in revenues for the three months ended October 1, 2021, as compared to the three months ended October 2, 2020, was primarily attributable to a net increase in volumes on certain programs and program wins.

The increase in revenues for the nine months ended October 1, 2021, as compared to the nine months ended October 2, 2020, was primarily attributable to a net increase in volumes on certain programs, program wins and an approximately $96 million reduction of the negative impacts of COVID-19 experienced during the prior year, partially offset by the completion of certain contracts.

The increase in operating income for the three months ended October 1, 2021, as compared to the three months ended October 2, 2020, was primarily due to increased volume on fixed unit price programs.

The increase in operating income for the nine months ended October 1, 2021, as compared to the nine months ended October 2, 2020, was primarily attributable to a net increase in volumes on higher margin programs, an approximately $63 million reduction of the negative impacts of COVID-19 experienced in the prior year and a net decrease in asset impairment charges of $8 million.

Three Months Ended Nine Months Ended

Corporate October 1,

2021 October 2,

2020 Dollar change Percent change October 1,

2021 October 2,

2020 Dollar change Percent change

2 unchanged sentences

NM - Not Meaningful

The increase in operating loss for the three and six months ended July 2, 2021, as compared to the three and six months ended July 3, 2020, was primarily attributable to an $81 million net gain recognized during the second quarter of fiscal 2020 upon receipt of proceeds related to the VirnetX, Inc.

("VirnetX") legal matter and a decrease in acquisition and integration costs.

The increase in operating loss for the nine months ended October 1, 2021, as compared to the nine months ended October 2, 2020, was primarily attributable to an $81 million net gain recognized during the second quarter of fiscal 2020 upon receipt of proceeds related to the VirnetX, Inc.

legal matter and a decrease in acquisition and integration costs.

LEIDOS HOLDINGS, INC.

Non-Operating Expense, net

Non-operating expense, net for the three months ended July 2, 2021 was $46 million as compared to $57 million for the three months ended July 3, 2020.

The change was primarily due to $12 million of debt discount and deferred financing costs written off related to refinancing activities in the prior year.

Non-operating expense, net for the six months ended July 2, 2021 was $92 million as compared to $119 million for the six months ended July 3, 2020.

Non-operating expense, net for the three months ended October 1, 2021 was $45 million, consistent with the three months ended October 2, 2020 of $44 million.

Non-operating expense, net for the nine months ended October 1, 2021 was $137 million as compared to $163 million for the nine months ended October 2, 2020.

The change was primarily due to $31 million of debt discount and deferred financing costs written off related to refinancing activities in the prior year.

Provision for Income Taxes

For the three months ended July 2, 2021, our effective tax rate was 23.8% compared to 19.8% for the three months ended July 3, 2020.

The increase in the effective tax rate was primarily due to an increase to state income taxes and the one-time effects of the increase to the UK tax rate.

For the six months ended July 2, 2021, our effective tax rate was 22.7% compared to 16.5% for the six months ended July 3, 2020.

The increase in the effective tax rate was primarily due to a decrease in benefits related to employee stock-based payments, an increase to state income taxes and a prior period release of a valuation allowance related to foreign tax credits.

For the three months ended October 1, 2021, our effective tax rate was 20.0% compared to 23.8% for the three months ended October 2, 2020.

The decrease in the effective tax rate was primarily due to a decrease in foreign taxes and an increase in research tax credits.

For the nine months ended October 1, 2021, our effective tax rate was 21.7% compared to 19.4% for the nine months ended October 2, 2020.

The increase in the effective tax rate was primarily due to a net decrease in benefits related to employee stock-based payments.

Beginning in 2022, the Tax Cuts and Jobs Act of 2017 eliminates the option to currently deduct research and development costs for tax purposes and requires taxpayers to amortize domestic and foreign research costs over five years and 15 years, respectively.

The House Ways and Means Committee has proposed tax legislation to delay the effective date of this change to 2026, but it is uncertain whether the proposed delay will ultimately be enacted into law.

If the 2022 effective date remains in place, our initial assessment is our cash from operations would materially decrease in 2022 and our net deferred tax assets would increase by a similar amount.

We are currently evaluating the potential impact on our cash flows from operations.

Bookings and Backlog

We recorded net bookings worth an estimated $3.8 billion and $7.6 billion during the three and six months ended July 2, 2021, as compared to $4.6 billion and $10.2 billion for the three and six months ended July 3, 2020.

We recorded net bookings worth an estimated $4.7 billion and $12.3 billion during the three and nine months ended October 1, 2021, as compared to $4.3 billion and $14.5 billion for the three and nine months ended October 2, 2020.

The estimated value of our total backlog was as follows:

July 2, 2021 July 3, 2020

October 1, 2021 October 2, 2020

Segment Funded Unfunded Total Funded Unfunded Total

4 unchanged sentences

Total $ 7,289 $ 27,403 $ 34,692 $ 6,844 $ 24,875 $ 31,719

The change in backlog for the Defense Solutions reportable segment reflects $751 million of backlog acquired as a result of the acquisitions of 1901 Group and Gibbs & Cox.

The increase in backlog includes $757 million of backlog acquired through business combinations in our Defense Solutions reportable segment.

Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts, both funded and unfunded.

Backlog does not include unexercised option periods and future potential task orders expected to be awarded under indefinite delivery/indefinite quantity ("IDIQ") contracts, General Services Administration Schedule or other master agreement contract vehicles, with the exception of certain IDIQ contracts where task orders are not competitively awarded and separately priced but instead are used as a funding mechanism, and where there is a basis for estimating future revenues and funding on future anticipated task orders.

Total backlog at July 2, 2021 included a positive impact of $244 million when compared to total backlog at July 3, 2020, due to exchange rate movements in the British pound and Australian dollar when compared to the U.S.

Total backlog at October 1, 2021 included a positive impact of $103 million when compared to total backlog at October 2, 2020, primarily due to the exchange rate movement in the British pound when compared to the U.S.

Backlog estimates are subject to change and may be affected by factors including modifications of contracts and foreign currency movements.

LEIDOS HOLDINGS, INC.

Liquidity and Capital Resources

As of July 2, 2021, we had $338 million in cash and cash equivalents.

As of October 1, 2021, we had $587 million in cash and cash equivalents.

Additionally, we have an unsecured revolving credit facility which can provide up to $750 million in additional borrowing, if required.

As of July 2, 2021, there were no borrowings outstanding under the credit facility and we were in compliance with the related financial covenants.

At July 2, 2021, and January 1, 2021, we had outstanding debt of $5.1 billion and $4.7 billion, respectively.

As of October 1, 2021, there were no borrowings outstanding under the revolving credit facility and we were in compliance with the related financial covenants.

At October 1, 2021, and January 1, 2021, we had outstanding debt of $5.1 billion and $4.7 billion, respectively.

On May 7, 2021, we entered into a Credit Agreement which provided for a senior unsecured term loan facility in an aggregate principal amount of $380 million.

LEIDOS HOLDINGS, INC.

We made principal payments on our long-term debt of $27 million and $53 million during the three and six months ended July 2, 2021, respectively, and $226 million and $228 million during the three and six months ended July 3, 2020, respectively.

This activity included required principal payments on our term loans of $24 million and $48 million during the three and six months ended July 2, 2021, and $24 million during the three and six months ended July 3, 2020.

During the three and six months ended July 3, 2020 we made additional payments of $2,050 million and $3,975 million, respectively, related to our refinancing activities.

We made principal payments on our long-term debt of $27 million and $80 million during the three and nine months ended October 1, 2021, respectively, and $477 million and $705 million during the three and nine months ended October 2, 2020, respectively.

This activity included required principal payments on our term loans of $24 million and $72 million during the three and nine months ended October 1, 2021, and $24 million and $48 million during the three and nine months ended October 2, 2020.

During the nine months ended October 2, 2020, we made additional payments of $3,975 million, related to our refinancing activities.

On September 1, 2020, we retired our $450 million senior unsecured notes due December 2020.

The senior unsecured term loans and notes contain financial covenants and customary restrictive covenants.

We were in compliance with all covenants as of July 2, 2021.

We were in compliance with all covenants as of October 1, 2021.

On July 12, 2021, Leidos, Inc.

established a commercial paper program in which we may issue short-term unsecured commercial paper notes not to exceed $750 million and have maturities of up to 397 days from the date of issuance (see "Note 12–Subsequent Events" ).

We paid dividends of $48 million and $98 million during the three and six months ended July 2, 2021, respectively, and $48 million and $99 million during the three and six months ended July 3, 2020, respectively.

During the three and six months ended July 2, 2021, we sold $228 million and $693 million, respectively, of accounts receivable under accounts receivable purchase agreements and received proceeds of $229 million and $693 million, respectively.

During the three and six months ended July 3, 2020, we sold $549 million and $1,113 million of accounts receivable under accounts receivable purchase agreements and received proceeds of $549 million and $1,112 million, respectively (see "Note 9–Sale of Accounts Receivable").

As of October 1, 2021, we did not have any Commercial Paper Notes outstanding.

We paid dividends of $51 million and $149 million during the three and nine months ended October 1, 2021, respectively, and $49 million and $148 million during the three and nine months ended October 2, 2020, respectively.

During the nine months ended October 1, 2021, we sold $693 million of accounts receivable under accounts receivable purchase agreements.

There were no sales of accounts receivable during the thee months ended October 1, 2021.

During the three and nine months ended October 2, 2020, we sold $753 million and $1,866 million of accounts receivable under accounts receivable purchase agreements and received proceeds of $752 million and $1,864 million, respectively.

Stock repurchases of Leidos common stock may be made on the open market or in privately negotiated transactions with third parties including through accelerated share repurchase agreements.

1 unchanged sentence

The repurchase program may be accelerated, suspended, delayed or discontinued at any time.

During the six months ended July 2, 2021, we made open market repurchases of our common stock for an aggregate purchase price of $100 million.

There were no share repurchases made under the Company’s share repurchase program during the second quarter ended July 2, 2021.

COVID-19 has negatively impacted the financial markets and may impact our liquidity;

we will continue to assess our liquidity needs as the pandemic evolves.

For the next 12 months, we anticipate that we will be able to meet our liquidity needs, including servicing our debt, through cash generated from operations, available cash balances, sales of accounts receivable and, if needed, borrowings under our revolving credit facility.

During the three and nine months ended October 1, 2021, we made open market repurchases of our common stock, under the Company's share repurchase program, for an aggregate purchase price of $137 million and $237 million, respectively.

The proposed legislation changes to the Tax Cuts and Jobs Act of 2017 and the potential for COVID-19 to affect the financial markets may impact our liquidity.

We will continue to assess our liquidity needs as the proposed tax legislation changes and pandemic evolve.

LEIDOS HOLDINGS, INC.

Summary of Cash Flows

The following table summarizes cash flow information for the periods presented:

Three Months Ended Six Months Ended

Three Months Ended Nine Months Ended

2021 October 2,

2020 October 1,

2021 October 2,

(in millions)

1 unchanged sentence

Net cash used in investing activities (53) (15) (693) (2,714)

Net cash provided by financing activities 313 709 165 1,870

Net (decrease) increase in cash, cash equivalents and restricted cash $ (66) $ 117 $ (219) $ (35)

Net cash provided by operating activities decreased $405 million for the three months ended July 2, 2021, when compared to the prior year quarter.

The decrease was primarily due to lower sale of accounts receivable of $122 million, higher tax payments of $95 million, timing of customer advance payments of $94 million and the receipt of $85 million of proceeds related to the VirnetX legal matter in the prior year quarter.

Net cash provided by operating activities decreased $538 million for the six months ended July 2, 2021, when compared to the prior year.

The decrease was primarily due to lower sale of accounts receivable of $225 million, higher tax payments of $103 million, timing of customer advance payments of $162 million, and the receipt of $85 million of proceeds related to the VirnetX legal matter in the prior year.

LEIDOS HOLDINGS, INC.

Net cash used in investing activities decreased $618 million for the three months ended July 2, 2021, when compared to the prior year quarter primarily due to the larger acquisition made in the prior year quarter for the SD&A Businesses compared to our current quarter acquisition of Gibbs & Cox (see "Note 3–Acquisitions, Goodwill and Intangible Assets") and lower capital expenditures in the current quarter.

Net cash used in investing activities decreased $2,059 million for the six months ended July 2, 2021, when compared to the prior year, primarily due to larger acquisitions made in the prior year for Dynetics and SD&A Businesses compared to our current year acquisitions of 1901 Group and Gibbs & Cox (see "Note 3–Acquisitions, Goodwill and Intangible Assets") and lower capital expenditures in the current year.

Net cash provided by financing activities decreased $396 million for the three months ended July 2, 2021 when compared to the prior year quarter.

The change was primarily due to a decrease of approximately $394 million from the net change of proceeds received from the issuance of debt, principal payments and payments for debt issuance costs.

Net cash provided by financing activities decreased $1,705 million for the six months ended July 2, 2021, when compared to the prior year.

The change was primarily due to a decrease of approximately $1,656 million from the net change of proceeds received from the issuance of debt, principal payments and payments for debt issuance costs and by $100 million of open market stock repurchases in the current year, partially offset by a $38 million increase in capital contributions received from our non-controlling interest.

Net cash (used in) provided by financing activities (209) (517) (44) 1,353

Net increase in cash, cash equivalents and restricted cash $ 303 $ 60 $ 84 $ 25

Net cash provided by operating activities decreased $27 million for the three months ended October 1, 2021, when compared to the prior year quarter.

The decrease was primarily due to the $92 million deferral of employer payroll taxes in the prior year and the timing of customer advance payments, partially offset by lower income tax payments of $34 million and other favorable working capital changes.

Net cash provided by operating activities decreased $565 million for the nine months ended October 1, 2021, when compared to the prior year.

The decrease was primarily due to lower sales of accounts receivable outstanding of $232 million, $92 million of deferral of employer payroll taxes in the prior year, higher income tax payments of $69 million, the receipt of $85 million of proceeds related to the VirnetX legal matter in the prior year and the timing of customer advance payments.

Net cash used in investing activities increased $38 million for the three months ended October 1, 2021, when compared to the prior year quarter primarily due to an additional inconsequential acquisition made during the current quarter (see "Note 3–Acquisitions, Goodwill and Intangible Assets").

Net cash used in investing activities decreased $2,021 million for the nine months ended October 1, 2021, when compared to the prior year, primarily due to larger acquisitions made in the prior year for Dynetics and the SD&A Businesses compared to our material current year acquisitions, 1901 Group and Gibbs & Cox (see "Note 3–Acquisitions, Goodwill and Intangible Assets") and lower capital expenditures in the current year.

Net cash used in financing activities decreased $308 million for the three months ended October 1, 2021 when compared to the prior year quarter.

The change was primarily due to the early repayment to retire our $450 million senior unsecured notes in the prior year quarter, partially offset by $137 million of open market stock repurchases in the current year quarter.

Net cash used in financing activities increased $1,397 million for the nine months ended October 1, 2021, when compared to the prior year.

The change was primarily due to a decrease of approximately $1,206 million from the net change of proceeds received from the issuance of debt, principal payments and payments for debt issuance

costs and by $237 million of open market stock repurchases in the current year, partially offset by a net $34 million

increase in capital contributions received from our non-controlling interest.

Off-Balance Sheet Arrangements

11 unchanged sentences

The summarized balance sheet for Leidos Holdings, Inc.

and Leidos, Inc., net of eliminations, as of July 2, 2021 was as follows (in millions):

and Leidos, Inc., net of eliminations, as of October 1, 2021 was as follows (in millions):

Balance Sheet

12 unchanged sentences

The summarized statements of income for Leidos Holdings, Inc.

and Leidos, Inc., net of eliminations, for the three and six months ended July 2, 2021 were as follows (in millions):

and Leidos, Inc., net of eliminations, for the three and nine months ended October 1, 2021 were as follows (in millions):

Statements of Income

Three Months Ended Six Months Ended

Three Months Ended Nine Months Ended

Revenues, net $ 2,369 $ 6,885

6 unchanged sentences

There were no material changes to our critical accounting policies, estimates or judgments during the period covered by this report from those discussed in our Annual Report on Form 10-K for the year ended January 1, 2021 except for the elimination of the Income Taxes critical accounting policy.

LEIDOS HOLDINGS, INC.

Recently Adopted and Issued Accounting Standards

For a discussion of these items, see "Note 1–Basis of Presentation and Summary of Significant Accounting Policies" of the notes to the condensed consolidated financial statements contained within this Quarterly Report on Form 10-Q.

LEIDOS HOLDINGS, INC.

Quantitative and Qualitative Disclosures About Market Risk.

1 unchanged sentence

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Management’s Discussion and Analysis